Clinical Trial Update: Statin and Atheroma Vulnerability Evaluation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of a statin on atheroma vulnerability in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Statin (unspecified)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED